Crossmark

Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis

Crossref DOI link: https://doi.org/10.1136/annrheumdis-2019-215119

Published Print: 2019-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Mor, Adi

Segal Salto, Michal https://orcid.org/0000-0001-5061-8683
Katav, Avi

Barashi, Neta

Edelshtein, Victoria

Manetti, Mirko

Levi, Yair

George, Jacob

Matucci-Cerinic, Marco
License Information

Text and Data Mining valid from 2019-09-01

Text and Data Mining valid from 2019-09-01

Version of Record valid from 2019-05-25
More Information

This article is maintained by: Elsevier

Article Title: Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis

Journal Title: Annals of the Rheumatic Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1136/annrheumdis-2019-215119

Content Type: article

Copyright: Copyright © 2019 © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.